Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/130455
Full metadata record
DC FieldValueLanguage
dc.creatorPereira, F.
dc.creatorAlmeida, J.R.
dc.creatorPaulino, M.
dc.creatorGrilo, I.R.
dc.creatorMacedo, H.
dc.creatorCunha, I.
dc.creatorSobral, R.G.
dc.creatorVasconcelos, V.
dc.creatorGaudêncio, S.P.
dc.date.accessioned2020-12-04T15:17:24Z-
dc.date.available2020-12-04T15:17:24Z-
dc.date.issued2020
dc.identifier.issnISSN 1660-3397
dc.identifier.urihttps://hdl.handle.net/10216/130455-
dc.description.abstractThe undesired attachment of micro and macroorganisms on water-immersed surfaces, known as marine biofouling, results in severe prevention and maintenance costs (billions €/year) for aquaculture, shipping and other industries that rely on coastal and off-shore infrastructures. To date, there are no sustainable, cost-effective and environmentally safe solutions to address this challenging phenomenon. Therefore, we investigated the antifouling activity of napyradiomycin derivatives that were isolated from actinomycetes from ocean sediments collected off the Madeira Archipelago. Our results revealed that napyradiomycins inhibited ≥80% of the marine biofilm-forming bacteria assayed, as well as the settlement of Mytilus galloprovincialis larvae (EC50 < 5 µg/ml and LC50/EC50 >15), without viability impairment. In silico prediction of toxicity end points are of the same order of magnitude of standard approved drugs and biocides. Altogether, napyradiomycins disclosed bioactivity against marine micro and macrofouling organisms, and non-toxic effects towards the studied species, displaying potential to be used in the development of antifouling products.
dc.description.sponsorshipThis work was supported by the Applied Molecular Biosciences Unit-UCIBIO which is financed by national funds from FCT/MCTES (UID/Multi/04378/2019). It was also supported by CIIMAR which is financed by national funds from FCT/MCTES (UID/Multi/04423/2019). Funding from the 7th Framework Programme (FP7/2007–2013) under grant agreement PCOFUND-GA-2009-246542, DFRH/WIIA/102/2011 and SFRH/BI/52130/ 2013. Financial support provided by FCT/MCTES through grants IF/00700/2014 and SFRH/BPD/110020/2015. Funding also provided by the projects PTDC/QUI-QUI/119116/2010, PTDC/BIA-MIC/31645/2017, PTDC/BTA-GES/ 32359/2017, and PTDC/BTA-BTA/31422/2017 (POCI-01-0145-FEDER-031422), financed by FCT/MCTES, COMPETE2020 and PORTUGAL2020. The NMR spectrometers are part of The National NMR Facility, supported by FCT (RECI/BBB-BQB/0230/2012).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofMarine Drugs 2020, 18(1), 63
dc.rightsopenAccess
dc.subjectActinomycetes
dc.subjectAntibiofilm
dc.subjectAntifouling
dc.subjectBiofouling
dc.subjectBioprospection
dc.subjectDrug discovery
dc.subjectHybrid isoprenoids
dc.subjectMarine natural products
dc.subjectMeroterpenoids
dc.subjectNapyradiomycins
dc.titleAntifouling napyradiomycins from marine-derived actinomycetes streptomyces aculeolatus
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoCentro Interdisciplinar de Investigação Marinha e Ambiental
dc.identifier.doihttps://doi.org/10.3390/md18010063
dc.relation.publisherversionhttps://www.mdpi.com/1660-3397/18/1/63
Appears in Collections:CIIMAR - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Pereira_F_2020.pdf1.74 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.